<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00894920</url>
  </required_header>
  <id_info>
    <org_study_id>3114301</org_study_id>
    <secondary_id>R01DK079892-01</secondary_id>
    <secondary_id>107068</secondary_id>
    <nct_id>NCT00894920</nct_id>
  </id_info>
  <brief_title>Biotin Status in Pregnancy</brief_title>
  <official_title>Biotin Status in Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to estimate the number of pregnant women who, during pregnancy,
      have low levels of the vitamin biotin. The hypothesis of this study is that a large number of
      pregnant women will have low biotin levels. This information will be used to later determine
      if low biotin levels during pregnancy cause certain birth defects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lymphocyte propionyl-CoA carboxylase (PCC) activities</measure>
    <time_frame>2-3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary biotin excretion</measure>
    <time_frame>2-3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary 3-hydroxyisovaleric acid (3HIA) excretion</measure>
    <time_frame>2-3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other biotin-related indicators in urine and blood</measure>
    <time_frame>2-3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">124</enrollment>
  <condition>Biotin Deficiency</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>biotin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>biotin</intervention_name>
    <description>capsule approximately 30 mcg daily 21 days</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>biotin</intervention_name>
    <description>capsule 300 mcg daily 21 days</description>
    <arm_group_label>biotin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-40

          -  in early pregnancy (less than 15 weeks gestation)

          -  under care of physician

          -  normal pregnancy

          -  taking prenatal vitamin with less than 30 mcg biotin

        Exclusion Criteria:

          -  prenatal vitamin with greater than 30 mcg biotin

          -  antibiotic use

          -  known renal disease

          -  drug, alcohol abuse

          -  gastric bypass

          -  daily diet high in biotin

          -  use of certain meal replacement products high in biotin

          -  previous history of children with birth defects
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald M Mock, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.uams.edu</url>
    <description>Website for University of Arkansas for Medical Sciences</description>
  </link>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2009</study_first_submitted>
  <study_first_submitted_qc>May 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2009</study_first_posted>
  <last_update_submitted>February 26, 2015</last_update_submitted>
  <last_update_submitted_qc>February 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>biotin</keyword>
  <keyword>deficiency</keyword>
  <keyword>pregnancy</keyword>
  <keyword>lymphocyte propionyl-CoA carboxylase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biotinidase Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biotin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

